Articles

11. Considerations For Improving Patient Recruitment Into Clinical Trials 3/27/2012

    Clinical trials account for nearly 40% of the US pharma research budget and total around $7B per year and the estimated cost of patient recruitment is 40% of the total budget, or $1.89B. Thus, patient recruitment is the very weak link in the development pipeline and one that an experienced investor would want to know what steps are being taken to address the issue and thus accelerate the time to market and thus profitability.
     

12. Sterile Clinical Trial Material Formulation & Filling 3/26/2012
    DSM offers sterile clinical trial formulation and filling that meets the unique needs of global pharmaceutical and biotech customers.
13. Oncology Services Brochure 3/15/2012
    A leading western CRO in Russia, ClinStar offers invaluable experience to enhance your study execution, resulting in higher-quality results. We offer local regulatory, customs and logistical expertise, as well as clinical teams that are therapeutically trained in oncology.
14. CNS Services Brochure 3/15/2012
    A leading western CRO in Russia, ClinStar offers invaluable experience to enhance your study execution, resulting in higher-quality results. We offer local regulatory, customs and logistical expertise as well as clinical teams that are therapeutically trained in CNS diseases.
15. Endocrinology Services Brochure 3/15/2012
    A leading western CRO in Russia, ClinStar offers invaluable experience and strong medical backgrounds to enhance your study execution, resulting in higher-quality results. We offer local regulatory, customs and logistical expertise, as well as clinical teams that are therapeutically trained in endocrinology.
16. Cardiovascular Services Brochure 3/14/2012
    A leading western CRO in Russia, ClinStar offers invaluable experience and medical support to enhance your study execution, resulting in higherquality results. We offer local regulatory, customs and logistical expertise as well as clinical teams that are therapeutically trained in cardiovascular diseases.
17. Brochure: RHOBUST® Downstream Processing Technology 2/22/2012
    Rhobust® technology is a downstream processing technology for the manufacturing of recombinant proteins and antibodies.
18. Brochure: XD® Technology: Improve Biopharmaceutical Production 2/22/2012
    DSM's XD® Technology has been developed to drive yield improvements in the production of biopharmaceuticals.
19. Brochure: Finished Dosage Forms 2/21/2012
    DSM is a global provider of finished dosage form manufacturing and related services to pharmaceutical and biopharmaceutical markets.
20. PRA Exceeds Tough Enrollment Goals: Service Delivery Model Drives Positive Results 2/20/2012

    Changes in resources for both the client and PRA teams led to significant challenges with the start-up and enrollment activities in Europe and North America.